Coya Therapeutics, Inc.
PublicCoya Therapeutics, Inc. is now publicly traded
The data on this page reflects Coya Therapeutics, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jan 30, 2026
Total Funding Raised
$11.1M
Company Overview
Coya Therapeutics, Inc. has raised $11.1M. It was founded in 2020.
Coya Therapeutics, Inc. is a biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells (“Tregs”) to target systemic inflammation and neuroinflammation.
AI Layer
Non-AI
Coya Therapeutics, Inc. Comparables
Compare Coya Therapeutics, Inc. with similar companies based on industry and business-model similarity.
No comparables are published for Coya Therapeutics, Inc.. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Coya Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jan 30, 2026 |
For institutional investors. Book with your work email.
Coya Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Greenlight Capital | Private Placement |
Coya Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.